Skip to content

Explore Courses | Elder Research | Contact | LMS Login

Statistics.com: Data Science, Analytics & Statistics Courses
  • Curriculum
    • Curriculum
    • About Us
    • Testimonials
    • Management Team
    • Faculty Search
    • Teach With Us
    • Credit & Credentialing
  • Courses
    • Explore Courses
    • Course Calendar
    • About Our Courses
    • Course Tour
    • Test Yourself!
  • Mastery Series
    • Mastery Series Program
    • Bayesian Statistics
    • Business Analytics
    • Healthcare Analytics
    • Marketing Analytics
    • Operations Research
    • Predictive Analytics
    • Python for Analytics
    • R Programming
    • Rasch & IRT
    • Spatial Statistics
    • Statistical Modeling
    • Survey Statistics
    • Text Mining and Analytics
  • Certificates
    • Certificate Program
    • Analytics for Data Science
    • Biostatistics
    • Programming for Data Science – R (Novice)
    • Programming for Data Science – R (Experienced)
    • Programming for Data Science – Python (Novice)
    • Programming for Data Science – Python (Experienced)
    • Social Science
  • Degrees
    • Degree Programs
    • Computational Data Analytics Certificate of Graduate Study from Rowan University
    • Health Data Management Certificate of Graduate Study from Rowan University
    • Data Science Analytics Master’s Degree from Thomas Edison State University (TESU)
    • Data Science Analytics Bachelor’s Degree – TESU
    • Mathematics with Predictive Modeling Emphasis BS from Bellevue University
  • Enterprise
    • Organizations
    • Higher Education
  • Resources
    • Blog
    • FAQs & Knowledge Base
    • Glossary
    • Site Map
    • Statistical Symbols
    • Weekly Brief Newsletter Signup
    • Word of the Week
Menu Close
  • Curriculum
    • Curriculum
    • About Us
    • Testimonials
    • Management Team
    • Faculty Search
    • Teach With Us
    • Credit & Credentialing
  • Courses
    • Explore Courses
    • Course Calendar
    • About Our Courses
    • Course Tour
    • Test Yourself!
  • Mastery Series
    • Mastery Series Program
    • Bayesian Statistics
    • Business Analytics
    • Healthcare Analytics
    • Marketing Analytics
    • Operations Research
    • Predictive Analytics
    • Python for Analytics
    • R Programming
    • Rasch & IRT
    • Spatial Statistics
    • Statistical Modeling
    • Survey Statistics
    • Text Mining and Analytics
  • Certificates
    • Certificate Program
    • Analytics for Data Science
    • Biostatistics
    • Programming for Data Science – R (Novice)
    • Programming for Data Science – R (Experienced)
    • Programming for Data Science – Python (Novice)
    • Programming for Data Science – Python (Experienced)
    • Social Science
  • Degrees
    • Degree Programs
    • Computational Data Analytics Certificate of Graduate Study from Rowan University
    • Health Data Management Certificate of Graduate Study from Rowan University
    • Data Science Analytics Master’s Degree from Thomas Edison State University (TESU)
    • Data Science Analytics Bachelor’s Degree – TESU
    • Mathematics with Predictive Modeling Emphasis BS from Bellevue University
  • Enterprise
    • Organizations
    • Higher Education
  • Resources
    • Blog
    • FAQs & Knowledge Base
    • Glossary
    • Site Map
    • Statistical Symbols
    • Weekly Brief Newsletter Signup
    • Word of the Week

Blog

Industry Spotlight – Pharma

  • May 13, 2019
  • , 9:38 pm

The cost of bringing a new drug to market is over $2 billion, by some estimates. This covers the R&D, clinical trial testing and regulatory approval costs of the drug that makes it through the whole process, and also the same costs of the 9 drugs that don’t make it, for each drug that does. Nonetheless, despite the high-stakes gambling involved, it is a crowded space, and one that relies heavily on substantial entry-level capital, partnerships and licensing deals.

Focusing on the development of new drugs (and leaving aside generics and distributor deals), at the entry end, there are “startup” companies just coming into the market on the strength of a very specific technology. Akouos, for example, has licensed precision gene therapy for hearing loss from Massachusetts Eye and Ear Hospital and is commercializing it. Some of these startups may have no revenue prospects for years. Last year, Allogene purchased from Pfizer licenses to compounds to treat blood cancer, and is carrying the research forward. Formed in April 2018, Allogen went public in late 2018 and has just started its first Phase I trial.

At the top end are companies like Pfizer and Novartis, with annual drug sales in the range of $50 billion. For these companies, one challenge is meeting market expectations for growth when blockbuster drugs from the past go off patent, and stop producing revenue. Pfizer’s two big sellers, Lipitor and Viagra, produced a total of nearly $15 billion in revenue at their respective peaks, and dropped to less than $2 billion after going off patent.

Huge R&D costs, especially those associated with failed drugs, place enormous pressures on profits from the winners while they are under patent. The basic patent period for drugs is 20 years, though there are extensions to account for lengthy FDA approval periods. Since companies file for patents early in the development/approval process to protect their IP, time is of the essence in testing the drug and shepherding it through approval. Some of the approaches to taking full advantage of this time include:

  • Licensing patented technology to others who are better equipped to take rapid advantage of it

  • Use of contract research organizations (CRO’s) to conduct the trials

  • Using distribution partnerships for rapid rollouts once approval is granted

  • Careful use of statistical methods to optimize the required randomized trials

  • Judicious reliance on statistical expertise to avoid costly errors that can invalidate results

Subscribe to the Blog

You have Successfully Subscribed!

By submitting your information, you agree to receive email communications from statistics.com. All information submitted is subject to our privacy policy. You may opt out of receiving communications at any time.

Categories

Recent Posts

  • March 9: Statistics and Data Science in Practice March 7, 2021
  • Feb 23: Statistics and Data Science in Practice March 5, 2021
  • Word of the Week – Ruin Theory March 4, 2021

About Statistics.com

Statistics.com offers academic and professional education in statistics, analytics, and data science at beginner, intermediate, and advanced levels of instruction. Statistics.com is a part of Elder Research, a data science consultancy with 25 years of experience in data analytics.

Latest Blogs

  • March 9: Statistics and Data Science in Practice
    March 7, 2021/
    0 Comments
  • Feb 23: Statistics and Data Science in Practice
    March 5, 2021/
    0 Comments
  • Word of the Week – Ruin Theory
    March 4, 2021/
    0 Comments

Social Networks

Linkedin-in
Twitter
Facebook-f
Youtube

Contact

The Institute for Statistics Education
4075 Wilson Blvd, 8th Floor
Arlington, VA 22203
(571) 281-8817

ourcourses@statistics.com

© Copyright 2021 - Statistics.com, LLC | All Rights Reserved | Privacy Policy | Terms of Use

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept